Oral Low-Dose Naltrexone in the Treatment of Frontal Fibrosing Alopecia and Lichen Planopilaris: An Uncontrolled Open-Label Prospective Study

Background Frontal fibrosing alopecia (FFA) and lichen planopilaris (LPP) is scarring alopecias with limited evidence supporting their treatment options. We investigated the use of low-dose naltrexone (3 mg oral daily) as adjunctive therapy in the treatment of FFA and LPP. Methods A single-center, u...

Descripción completa

Detalles Bibliográficos
Autores principales: Hamel, Remi K, Chen, Ling, O’Connell, Cailin, Mann, Caroline
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2023
Materias:
Dermatology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9950001/
https://www.ncbi.nlm.nih.gov/pubmed/36843712
http://dx.doi.org/10.7759/cureus.34169

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9950001/
https://www.ncbi.nlm.nih.gov/pubmed/36843712
http://dx.doi.org/10.7759/cureus.34169

Ejemplares similares